Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40
Condition(s):Fragile X SyndromeLast Updated:December 8, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Fragile X SyndromeLast Updated:December 8, 2022Withdrawn
Condition(s):Fragile X SyndromeLast Updated:February 3, 2021Completed
Condition(s):Fragile X SyndromeLast Updated:March 5, 2024Recruiting
Condition(s):Fragile X SyndromeLast Updated:February 15, 2024Not yet recruiting
Condition(s):Fragile X SyndromeLast Updated:February 28, 2024Recruiting
Condition(s):Fragile X SyndromeLast Updated:July 6, 2016Completed
Condition(s):Fragile X SyndromeLast Updated:January 25, 2024Enrolling by invitation
Condition(s):Fragile X SyndromeLast Updated:February 22, 2024Recruiting
Condition(s):Fragile X SyndromeLast Updated:February 22, 2024Recruiting
Condition(s):Fragile X SyndromeLast Updated:June 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.